PE20000422A1 - Compuestos de amidina - Google Patents

Compuestos de amidina

Info

Publication number
PE20000422A1
PE20000422A1 PE1999000295A PE00029599A PE20000422A1 PE 20000422 A1 PE20000422 A1 PE 20000422A1 PE 1999000295 A PE1999000295 A PE 1999000295A PE 00029599 A PE00029599 A PE 00029599A PE 20000422 A1 PE20000422 A1 PE 20000422A1
Authority
PE
Peru
Prior art keywords
alkyl
alcoxycarbonyl
conh
carboxy
link
Prior art date
Application number
PE1999000295A
Other languages
English (en)
Inventor
Susumu Katoh
Katsuyuki Yokota
Mikio Hayashi
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of PE20000422A1 publication Critical patent/PE20000422A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE REFIERE A UNA AMIDINA DE FORMULA I, DONDE R ES UN GRUPO a, b, c; R4 ES H, OH, ALQUILO, ALCOXI, HALOGENO; R5 ES H, CIANO, CARBOXI, ALCOXICARBONILO; R6 ES H, CICLOALQUILO, OH, CARBOXI, ALCOXICARBONILO; X2 ES O, S, -SO2-, -SO2NH-, ENLACE; X3 ES -(CH2)m-; X4 ES -CO-, -C(=NH)-, -SO2-, -CONH-, -CSNH-, -SO2NH-, (CH2)rCONH-, ENTRE OTROS; r ES 0-3, UN ENLACE; X5 ES ALQUILENO C1-C6, ALQUENILENO C2-C6, UN ENLACE; R7 ES H, ALQUILO, -C(=R9)(R10); R9 ES O, S, NH, NR11, R11 ES ALQUILO, ARALQUILO; R8 ES H, ALQUILO, CICLOALQUILO, ENTRE OTROS; Y1 ES O, -NH-, -CONH-, -NR12-; R12 ES H, ALQUILO, ARILO; Y4 ES -CO-, -CO2-, -COCO2-, -SO2-, ENTRE OTROS; Y2 ES O, S, UN ENLACE; Y3 ES GRUPO FENIL, PIRIDIL, d; s Y t SON 1-3; Y4 ES O, -CO-, -CO2-, -SO2-, -CONH-, ENTRE OTROS; Y5 ES -(CH2)p-, (ChAk-CH2)p`, -(CH2)p-CAkAk'-(CH2)p''-; Ak Y Ak' SON ALQUILO; p ES 0-3; p' Y p'' SON 0-2; A ES UN GRUPO FENIL, PIPERIDINIL, e; R14 ES CARBOXI, ALCOXICARBONILO; j ES 1-2; k ES 0-1; m Y n SON 0-3; R1, R2, Y R3 SON H, OH, ALQUILO, ARILO. SON COMPUESTOS PREFERIDOS 7-[1-(PIRIDI-4-NIL)PIPERIDI-4-NILMETOXI]-1,2,3,4-TETRAHIDROISOQUINOLINA-2-CARBOXAMIDINA; 7-[1-(QUINOLI-4-NIL)PIPERIDI-4-NILMETOXI]-1,2,3,4-TETRAHIDROISOQUINOLINA -2-CARBOXAMIDINA, ENTRE OTROS. EL COMPUESTO I ES UN INHIBIDOR DEL FACTOR Xa Y PUEDE SER UTIL PARA INHIBIR LA COAGULACION SANGUINEA, TROMBOSIS
PE1999000295A 1998-04-10 1999-04-12 Compuestos de amidina PE20000422A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP11623398 1998-04-10
JP23786998 1998-08-25

Publications (1)

Publication Number Publication Date
PE20000422A1 true PE20000422A1 (es) 2000-05-19

Family

ID=26454606

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000295A PE20000422A1 (es) 1998-04-10 1999-04-12 Compuestos de amidina

Country Status (23)

Country Link
US (2) US6562828B1 (es)
EP (1) EP1070714B1 (es)
KR (1) KR100416111B1 (es)
CN (1) CN1305470A (es)
AR (1) AR015269A1 (es)
AT (1) ATE272630T1 (es)
AU (1) AU752588B2 (es)
BR (1) BR9910122A (es)
CA (1) CA2327488A1 (es)
CO (1) CO5021130A1 (es)
DE (1) DE69919149D1 (es)
HU (1) HUP0101137A3 (es)
ID (1) ID28266A (es)
IL (1) IL138899A0 (es)
NO (1) NO20005083L (es)
NZ (1) NZ508101A (es)
PE (1) PE20000422A1 (es)
PL (1) PL343424A1 (es)
RU (1) RU2201927C2 (es)
SG (1) SG74717A1 (es)
SK (1) SK15072000A3 (es)
TR (1) TR200002904T2 (es)
WO (1) WO1999052895A1 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE251141T1 (de) 1995-03-10 2003-10-15 Berlex Lab Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien
US6686364B2 (en) 1997-12-08 2004-02-03 Berlex Laboratories, Inc. Benzamidine derivatives and their use as anti-coagulants
EP1122252A4 (en) * 1998-10-16 2002-06-26 Takeda Chemical Industries Ltd CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM
US6262088B1 (en) 1998-11-19 2001-07-17 Berlex Laboratories, Inc. Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
US6350761B1 (en) 1999-07-30 2002-02-26 Berlex Laboratories, Inc. Benzenamine derivatives as anti-coagulants
WO2001056989A2 (en) * 2000-02-01 2001-08-09 Cor Therapeutics, Inc. Inhibitors of factor xa
EP1268432A1 (en) 2000-03-24 2003-01-02 Millenium Pharmaceuticals, Inc. ISOQUINOLONE INHIBITORS OF FACTOR Xa
EP1268452A1 (en) * 2000-03-24 2003-01-02 Millenium Pharmaceuticals, Inc. BICYCLIC SULFONYL AMINO INHIBITORS OF FACTOR Xa
US20040048780A1 (en) * 2000-05-10 2004-03-11 The Trustees Of Columbia University In The City Of New York Method for treating and preventing cardiac arrhythmia
US7393652B2 (en) * 2000-05-10 2008-07-01 The Trustees Of Columbia University In The City Of New York Methods for identifying a chemical compound that directly enhances binding of FKBP12.6 to PKA-phosphorylated type 2 ryanodine receptor (RyR2)
US8022058B2 (en) 2000-05-10 2011-09-20 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US20040229781A1 (en) * 2000-05-10 2004-11-18 Marks Andrew Robert Compounds and methods for treating and preventing exercise-induced cardiac arrhythmias
US7718644B2 (en) * 2004-01-22 2010-05-18 The Trustees Of Columbia University In The City Of New York Anti-arrhythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2) and uses thereof
US7879840B2 (en) * 2005-08-25 2011-02-01 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
US6489125B1 (en) * 2000-05-10 2002-12-03 The Trustees Of Columbia University In The City Of New York Methods for identifying chemical compounds that inhibit dissociation of FKBP12.6 binding protein from type 2 ryanodine receptor
US20060293266A1 (en) * 2000-05-10 2006-12-28 The Trustees Of Columbia Phosphodiesterase 4D in the ryanodine receptor complex protects against heart failure
CA2416384A1 (en) * 2000-07-17 2003-01-16 Takeda Chemical Industries, Ltd. Sulfone derivatives, their production and use
DE10110325A1 (de) * 2001-03-03 2002-09-05 Merck Patent Gmbh Phenylderivate 2
CA2473236A1 (en) 2002-01-10 2003-07-24 Neurogen Corporation Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1h-benzoimidazole analogues
AU2003235895A1 (en) * 2002-05-09 2003-11-11 Mochida Pharmaceutical Co., Ltd. Process for producing 1-(4-pyridyl)-4-piperidone
US7544678B2 (en) * 2002-11-05 2009-06-09 The Trustees Of Columbia University In The City Of New York Anti-arrythmic and heart failure drugs that target the leak in the ryanodine receptor (RyR2)
WO2004048363A1 (ja) * 2002-11-22 2004-06-10 Takeda Pharmaceutical Company Limited イミダゾール誘導体、その製造法および用途
CN100513398C (zh) 2002-12-03 2009-07-15 Axys药物公司 作为因子viia抑制剂的2-(2-羟基联苯-3-基)-1h-苯并咪唑-5-甲脒衍生物
JP2007525165A (ja) 2003-03-07 2007-09-06 トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク タイプ１ライアノジン受容体に基づく方法
EP1479676A1 (en) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Benzimidazole-derivatives as factor xa inhibitors
US7741341B2 (en) * 2003-05-19 2010-06-22 Sanofi-Aventis Deutschland Gmbh Benzimidazole-derivatives as factor Xa inhibitors
US7378409B2 (en) 2003-08-21 2008-05-27 Bristol-Myers Squibb Company Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
JP4355917B2 (ja) 2003-10-29 2009-11-04 信越化学工業株式会社 含窒素有機化合物、レジスト材料及びパターン形成方法
US8710045B2 (en) * 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
DE102004016605A1 (de) * 2004-04-03 2005-10-20 Merck Patent Gmbh Thiocarbamoylproline
TWI396686B (zh) * 2004-05-21 2013-05-21 Takeda Pharmaceutical 環狀醯胺衍生物、以及其製品和用法
FR2870846B1 (fr) 2004-05-25 2006-08-04 Sanofi Synthelabo Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique
NZ552501A (en) * 2004-08-11 2010-03-26 Kyorin Seiyaku Kk Novel cyclic aminobenzoic acid derivative
EP1847527A4 (en) 2005-02-02 2009-04-08 Ajinomoto Kk NEW BENZAMIDINE DERIVATIVE
EP1862464A4 (en) * 2005-03-23 2010-08-25 Kyorin Seiyaku Kk NEW CYCLIC AMINOPHENYL ALKANIC ACID DERIVATIVE
US7709516B2 (en) * 2005-06-17 2010-05-04 Endorecherche, Inc. Helix 12 directed non-steroidal antiandrogens
US7704990B2 (en) * 2005-08-25 2010-04-27 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the RyR receptors
EP1790646A1 (fr) * 2005-11-24 2007-05-30 Sanofi-Aventis Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3.
US20080186971A1 (en) * 2007-02-02 2008-08-07 Tarari, Inc. Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
EP2311810A4 (en) * 2008-07-11 2012-04-04 Ajinomoto Kk AMIDINE DERIVATIVE
AR080374A1 (es) 2010-03-05 2012-04-04 Sanofi Aventis Procedimiento para la preparcion de 2-(ciclohexilmetil)-n-(2-((2s)-1-metilpirrolidin-2-il) etil)- 1,2,3,4-tetrahidroisoquinolin-7- sulfonamida
KR101499696B1 (ko) * 2013-10-16 2015-03-09 한국식품연구원 젓갈 유래 엔테로코쿠스속 미생물 및 이를 이용하여 s-아데노실-l-메티오닌을 대량 생산하는 방법
CN103965113A (zh) * 2014-05-06 2014-08-06 四川大学 1-羟乙基-2-取代苯氧甲基苯并咪唑类化合物及其制备方法
EP3693358B1 (en) * 2017-10-04 2023-02-22 Japan Tobacco Inc. Nitrogen-containing heteroaryl compound, and pharmaceutical use thereof

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725388A (en) 1970-06-25 1973-04-03 Boehringer Sohn Ingelheim N-acyl-7-(n{41 -cycloalkyl-ureido-n{40 -sulfonyl)-isoquinolines and -benzazepines and alkali metal salts thereof
US4324794A (en) 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds
JPS59139357A (ja) 1983-01-28 1984-08-10 Torii Yakuhin Kk アミジン誘導体
DE4035961A1 (de) 1990-11-02 1992-05-07 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5710158A (en) 1991-05-10 1998-01-20 Rhone-Poulenc Rorer Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
CA2102780C (en) 1991-05-10 2007-01-09 Alfred P. Spada Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
US5721237A (en) 1991-05-10 1998-02-24 Rhone-Poulenc Rorer Pharmaceuticals Inc. Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
DE4127404A1 (de) 1991-08-19 1993-02-25 Thomae Gmbh Dr K Cyclische iminoderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
JP3048698B2 (ja) 1991-09-19 2000-06-05 第一製薬株式会社 アミジノ基置換芳香族化合物及びその塩
ZA928276B (en) * 1991-10-31 1993-05-06 Daiichi Seiyaku Co Aromatic amidine derivates and salts thereof.
JP3457694B2 (ja) * 1993-02-04 2003-10-20 第一製薬株式会社 インフルエンザ感染予防・治療薬
JP3388803B2 (ja) 1993-05-20 2003-03-24 第一製薬株式会社 光学活性７−アミジノナフタレン誘導体の製造法
HUT71345A (en) 1993-09-22 1995-11-28 Wellcome Found Bis(amidinobenzimidazolyl)alkanes and pharmaceutical compositions containing them
JPH07179407A (ja) 1993-11-12 1995-07-18 Green Cross Corp:The 新規縮合環系化合物またはその塩、およびその医薬用途
US6815461B1 (en) 1994-01-20 2004-11-09 The University Of North Carolina At Chapel Hill Method of inhibiting retroviral integrase
JPH0820532A (ja) 1994-07-05 1996-01-23 Dai Ichi Seiyaku Co Ltd 抗膵炎剤
WO1996016940A1 (fr) 1994-12-02 1996-06-06 Yamanouchi Pharmaceutical Co., Ltd. Nouveau derive d'amidinonaphtyle ou sel de celui-ci
US5693515A (en) 1995-04-28 1997-12-02 Arris Pharmaceutical Corporation Metal complexed serine protease inhibitors
US5612363A (en) 1995-06-02 1997-03-18 Berlex Laboratories, Inc. N,N-di(aryl) cyclic urea derivatives as anti-coagulants
JPH092977A (ja) 1995-06-21 1997-01-07 Dai Ichi Seiyaku Co Ltd 経口投与用医薬組成物
DE19530996A1 (de) * 1995-08-23 1997-02-27 Boehringer Mannheim Gmbh Cyclische Guanidine, Verfahren zu ihrer Herstellung und Arzneimittel
IL123293A (en) 1995-09-07 2003-06-24 Hoffmann La Roche Piperidine derivatives, their preparation and pharmaceutical compositions containing them
SI0796623T1 (en) 1996-03-20 2005-10-31 Baxter Aktiengesellschaft Pharmaceutical preparation for the treatment of blood coagulation disorders
WO1997045424A1 (en) 1996-05-31 1997-12-04 C & C Research Laboratories Aromatic amidine derivatives useful as selective thrombin inhibitors
HU224315B1 (hu) 1996-06-05 2005-07-28 Gyógyszerkutató Intézet Kft. Véralvadásgátló hatású peptidil-arginin-aldehid-származékok és a vegyületeket tartalmazó gyógyszerkészítmények
JPH1017549A (ja) * 1996-07-02 1998-01-20 Banyu Pharmaceut Co Ltd 二環性芳香族アミジン誘導体
HN1998000118A (es) 1997-08-27 1999-02-09 Pfizer Prod Inc 2 - aminopiridinas que contienen sustituyentes de anillos condensados.
US5942532A (en) 1997-09-05 1999-08-24 Ortho Pharmaceutical Corporation 2-substituted phenyl-benzimidazole antibacterial agents
KR20070049251A (ko) 1999-10-27 2007-05-10 타녹스 인코퍼레이티드 조직 인자 길항제 및 그의 사용 방법
US20020173507A1 (en) 2000-08-15 2002-11-21 Vincent Santora Urea compounds and methods of uses

Also Published As

Publication number Publication date
EP1070714A4 (en) 2002-10-30
US20040006099A1 (en) 2004-01-08
NO20005083D0 (no) 2000-10-09
NO20005083L (no) 2000-12-08
EP1070714B1 (en) 2004-08-04
EP1070714A1 (en) 2001-01-24
TR200002904T2 (tr) 2001-02-21
RU2201927C2 (ru) 2003-04-10
HUP0101137A2 (hu) 2001-10-28
SG74717A1 (en) 2000-08-22
SK15072000A3 (sk) 2001-08-06
HUP0101137A3 (en) 2003-03-28
AU752588B2 (en) 2002-09-26
PL343424A1 (en) 2001-08-13
CO5021130A1 (es) 2001-03-27
AR015269A1 (es) 2001-04-18
BR9910122A (pt) 2001-10-16
US6562828B1 (en) 2003-05-13
IL138899A0 (en) 2001-11-25
KR20010042606A (ko) 2001-05-25
ID28266A (id) 2001-05-10
DE69919149D1 (de) 2004-09-09
ATE272630T1 (de) 2004-08-15
NZ508101A (en) 2002-12-20
WO1999052895A1 (en) 1999-10-21
EP1070714A9 (en) 2005-10-19
CA2327488A1 (en) 1999-10-21
CN1305470A (zh) 2001-07-25
AU3167799A (en) 1999-11-01
KR100416111B1 (ko) 2004-01-31

Similar Documents

Publication Publication Date Title
PE20000422A1 (es) Compuestos de amidina
CO5200783A1 (es) Compuestos terapeuticos
ATE188472T1 (de) 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
NZ325449A (en) Naphthyl-substituted benzimidazole derivatives as anticoagulants
DK0765313T3 (da) N,N'-bis (quinolin-4-yl)-diaminderivater, fremstilling deraf og anvendelse deraf som midler mod malaria
PE20010467A1 (es) 1,2,4,5-tetrahidro-benzo[d]azepin como antagonista del receptor metabotropico de glutamato
RU2012110522A (ru) Гипотензивная комбинация валсартана и блокатора кальциевых каналов
CO5210884A1 (es) DERIVADOS DE 5H-TIAZOLO[3,2-a] PIRIMIDINA
ATE412629T1 (de) Benzamide und ähnliche inhibitoren von faktor xa
ATE264846T1 (de) Substituierte benzimidazol-derivaten und ihre verwendung zur behandlung retroviraler infektionen
PE20011348A1 (es) Agentes antivirales de imidazopiridina e imidazopimiridina
ES2079323B1 (es) Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
DE69623799D1 (de) Kondensierte tropanderivate als neurotransmitter-reuptake-inhibitoren
ATE416157T1 (de) Inhibitoren von integrin alpha-v-beta-6
CO4290421A1 (es) Antagonistas del receptor de aminoacidos excitativos
MX9704588A (es) Derivados de aril- y hetaril-sulfonamida, su preparacion y su uso como antagonistas de la endotelina.
ATE155465T1 (de) Phenoxy- oder phenoxyalkyl-piperidine als antivirale mittel
NZ322565A (en) Mercaptoalkykpeptidyl compounds having an imidazole substitutent and their use as inhibitors of matrix metalloproteinases and tumor necrosis factor
DK1189900T3 (da) Heterocykliske aminopyrrolidinderivater som melatonerge lægemidler
CO5140104A1 (es) Derivados de mevinolina y preparacion farmaceuticas que los contienen
AR018472A1 (es) Compuesto, composicion y metodo para el tratamiento de la perdida de cabello
CO5261540A1 (es) Derivados de 2-bencil-3-dimetilamino-1-fenil propano
CO5271703A1 (es) Compuestos quimicos
ATE225335T1 (de) Amide derivate als 5-ht1a liganden
NZ337749A (en) Benzimidazole derivative and their use in allergy-related disease

Legal Events

Date Code Title Description
FC Refusal